Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
US Foods reported Q3 2026 financial results with net sales growing 2.1% to $10.4 billion and net income rising 42.5% to $218 million. The company achieved 5.0% case growth in independent restaurants and completed the acquisition of Prime Line Distributors in October.
Term
Q3 2026
“Our third quarter results reflect the strength of our strategy and disciplined execution, with continued market share gains and strong earnings growth. We again delivered 5% Independent Restaurant case growth and extended our track record of share gains to 22 consecutive quarters with Independent Restaurants and 24 consecutive quarters with Healthcare.”
Dave Flitman, Chair of the Board and CEO
“Our third quarter performance reflects continued topline growth and EBITDA margin expansion, driven by ongoing operational excellence and disciplined cost management. Based on our year-to-date results and fourth quarter expectations, we have tightened our full-year outlook to reflect the reality of a sustained slower macroeconomic environment and the impact of elevated fuel costs.”
Eos Energy Enterprises reported record Q3 2026 revenue of $82.7 million, a 171% year-over-year increase driven by higher cube shipments. The company also announced a manufacturing consolidation plan to move operations from Turtle Creek to Thorn Hill, Pennsylvania, which is expected to result in $16-$18 million in restructuring charges but improve long-term gross margins.
“Our third quarter shows operating model improvement. We delivered our highest quarterly revenue, improved gross margin by 18 points sequentially, and brought Line 2 first-pass yield equal to Line 1 four times faster.”
Tapestry, Inc. reported net sales of $1.89 billion for the quarter ended September 26, 2026, a significant increase from $1.71 billion in the prior year. Net income rose to $360 million, or $1.76 per diluted share, driven by higher gross profit and operational growth under the company's 'Amplify' strategy.
Iron Mountain reported record third-quarter 2026 revenue of $2.0 billion, a 13.5% increase year-over-year, driven by strong growth in its data center, digital, and asset lifecycle management businesses. The company achieved record quarterly Adjusted EBITDA of $748 million and raised its full-year 2026 financial guidance while increasing its quarterly dividend by 15%.
Term
Q3 2026
“We are pleased to report another record performance in the third quarter that exceeded our expectations. Our outstanding results continue to reflect the combined strength of our physical records storage and growth businesses, supported by our team's commitment to customer value creation and disciplined operational execution.”
William L. Meaney, President and CEO of Iron Mountain
Warby Parker reported third quarter 2026 revenue of $244.7 million, a 10.4% increase year-over-year, driven by a 3.0% growth in active customers and higher average revenue per customer. The company achieved a net income of $5.6 million and opened 12 net new stores, ending the period with 364 locations. Management narrowed full-year revenue guidance to $966-$976 million while reaffirming Adjusted EBITDA targets.
Term
Q3 2026
“One week from today, on November 12, we'll begin accepting pre-orders for our first Intelligent Eyewear collection and look forward to delivering customer orders during the holiday season. We can't wait for customers to experience these remarkable products firsthand.”
Dave Gilboa, Co-Founder and Co-CEO of Warby Parker
“There's a tremendous amount happening across Warby Parker, from rolling out Warby Parker Care to expanding our retail footprint to launching our first Intelligent Eyewear collection. We're continuing to expand our products and services, build on the investments we've made over many years, like exams and insurance, and find new ways to serve our customers.”
Onity Group reported third quarter 2026 net income of $3 million and adjusted pre-tax income of $30 million, driven by improved servicing profitability. The company achieved a record operating efficiency ratio of 51% and ended the quarter with $343 billion in servicing UPB, up 9% year-over-year.
Term
Q3 2026
“Our third quarter results demonstrate the resilience of our balanced business and the progress we made to improve returns on a sequential quarter basis. Servicing profitability improved sequentially, more than offsetting declining Originations profitability. In a market environment that is increasingly favorable for Servicing and more challenging for Originations, our complementary businesses returned the Company to profitability and more than doubled adjusted return on equity from the prior quarter.”
Glen A. Messina, Chair, President and CEO
“Looking ahead, we are confident in Onity’s ability to perform through the interest rate cycle. With a sound strategy and proven track record of execution, we believe we are well positioned to navigate market challenges, capitalize on attractive opportunities and create value for shareholders.”
Chimera Investment Corporation reported a GAAP net loss of $194 million for the third quarter of 2026, driven by interest rate volatility and mortgage spread widening. Despite the loss, the company maintained strong liquidity and successfully launched its inaugural $291 million Prism securitization program. Residential loan origination volume grew 27% year-over-year to $1.1 billion.
Term
3 years
“The third quarter presented a challenging market environment, with significant credit spread widening and interest rate volatility putting pressure on our book value. Despite these headwinds, we are executing on our strategic priorities, most recently with the successful launch of Prism. Our focus is on disciplined capital allocation, maintaining strong liquidity and leveraging our expanded platform to drive long term shareholder value.”
Chimera Investment Corporation declared its fourth quarter 2026 cash dividends for its Series A, B, C, and D preferred stock. The dividends range from $0.50 to $0.6343 per share and are payable on December 30, 2026, to shareholders of record as of December 1, 2026.
Tapestry, Inc. reported fiscal 2027 first quarter results with revenue of $1.9 billion, an 11% increase year-over-year, driven by 16% growth at the Coach brand. The company exceeded its guidance for revenue, gross margin, and EPS, leading management to raise its full-year outlook and increase its capital return target to $2.0 billion.
“Our first quarter marked a powerful start to the year, with revenue, margin, and earnings growth ahead of expectations and strength around the world. Our Amplify strategy continues to bring new consumers to our brands through our distinctive combination of creativity, craftsmanship, and value. Building on this outperformance, we are raising our full year outlook, reflecting our confidence in the durability of our growth.”
Joanne Crevoiserat, Chief Executive Officer of Tapestry, Inc.
Vontier Corp reported Q3 2026 sales of $736.9 million, a 2.1% decrease year-over-year primarily due to the Teletrac Navman divestiture, though core sales grew 5.7%. The company raised its full-year 2026 adjusted EPS guidance to a range of $3.60 to $3.64 based on strong operating leverage and simplification initiatives.
Term
Q3 2026
“Vontier delivered a strong third quarter, with results exceeding our guidance across sales, margin, and EPS. Increasing adoption of our innovative products and solutions is contributing to above-market growth. Our simplification and 80/20 initiatives are delivering more meaningful operating leverage, with savings now tracking ahead of our original commitment. These dynamics are strengthening our earnings profile and give us the confidence to raise our full-year outlook.”
Mark Morelli, President and Chief Executive Officer
Zai Lab Limited filed its Q3 2026 report as a large accelerated filer, reporting 1,124,448,350 ordinary shares outstanding as of October 31, 2026. The filing outlines significant risk factors related to its operations in mainland China, including regulatory uncertainties, manufacturing compliance, and geopolitical tensions.
FS KKR Capital Corp reported third quarter 2026 net investment income of $0.46 per share and a net asset value of $18.28 per share. The company also highlighted the repurchase of approximately 6 million shares for $69 million during the quarter and declared a regular distribution of $0.44 per share plus a special distribution of $0.20 per share.
“During the third quarter, FSK continued making progress toward our previously stated strategic goals. During the quarter we repurchased approximately six million shares of common stock at a weighted average price of $11.24 per share, totaling approximately $69 million. In addition, we received full and partial repayments of portfolio investments totaling $442 million. As our investment team continues focusing on portfolio rotation, we expect our portfolio will move toward more first lien exposure.”
Michael C. Forman, Chief Executive Officer and Chairman
Zai Lab reported third quarter 2026 total revenues of $108.2 million, representing a 2% sequential increase in net product revenue. The company highlighted positive clinical data for its internally developed ADC, zocilurtatug pelitecan (zoci), in small cell lung cancer and expects 2027 to be a pivotal year with its first potential U.S. BLA submission.
Term
Q3 2026
“We are approaching a defining period for Zai Lab, as we advance toward bringing our first internally developed innovative medicines to patients globally. The strong first-line combination data for zocilurtatug pelitecan (zoci) presented at ESMO strengthen our confidence in its potential to become an ADC backbone of choice in small cell lung cancer.”
Dr. Samantha Du, Founder, Chairperson and Chief Executive Officer of Zai Lab
“This profile supports taking a standard chemotherapy-free regimen into a global Phase 3 study and gives us a strong foundation to build on with T-cell engager combinations. Our registrational programs in SCLC and neuroendocrine carcinomas are advancing toward readouts that could support our first U.S. BLA submission in 2027.”
Rafael G. Amado, M.D., President, Head of Global Research and Development at Zai Lab
Americold Realty Trust reported Q3 2026 financial results with total revenues of $691.6 million, a 4.2% increase year-over-year. The company recognized a significant one-time gain from the formation of a joint venture with EQT, which allowed for a $1.15 billion reduction in outstanding debt and a strengthened balance sheet.
“A combination of best-in-class execution and continued industry stabilization allowed us to deliver another strong quarter of operating and financial performance. Ongoing gains in occupancy, throughput and pricing, along with lower SG&A from our cost savings initiatives, contributed to year-over-year growth in revenue and NOI as well as AFFO of $0.35 per share for the quarter.”
Rob Chambers, CEO of Americold
“A significant achievement during the quarter was the closing of our joint venture with EQT. The transaction enabled us to reduce our outstanding debt by $1.15 billion, reducing net leverage ratio by a full turn and significantly strengthening our balance sheet and financial flexibility.”
Strategic Education, Inc. reported Q3 2026 revenue of $325.1 million, up 1.6% year-over-year, driven by growth in its Education Technology Services segment. The company recorded a $134.1 million non-cash impairment charge related to its Australia and New Zealand operations due to international student immigration constraints, resulting in a net loss of $98.3 million. Adjusted diluted EPS on a constant currency basis increased to $1.69 from $1.63 in the prior year.
NCR Voyix reported total revenue of $539 million for the third quarter of 2026, a decrease from $677 million in the prior year, primarily due to a significant drop in product revenue. Despite the revenue decline, the company achieved a net income of $24 million compared to a net loss of $19 million in the same period last year, driven by improved operating margins and income from discontinued operations.
Molson Coors Beverage Company reported Q3 2026 financial results, with net sales decreasing 1.6% to $2.93 billion. While U.S. GAAP net income improved significantly compared to a prior-year loss that included a massive impairment charge, underlying income before taxes fell 17.4% in constant currency due to external headwinds.
Term
Q3 2026
“Since launching Horizon 2030 earlier this year, we've been laying important groundwork for long-term success by building the portfolio, capabilities, routines, and operating discipline needed to perform more consistently across the business. We've taken decisive actions intended to strengthen our share trend performance, accelerate our portfolio transformation, simplify our cost structure, and return cash to shareholders. We believe our strategy is on the right track, but these outcomes are not yet scaled enough to offset the headwinds that we experienced in the third quarter.”
Rahul Goyal, President and Chief Executive Officer
“Our third quarter financial results reflect both the benefits of the deliberate actions we've taken under Horizon 2030 and the impact of external headwinds that intensified as the year progressed. Those pressures weighed on our performance in the quarter and are likely to remain a factor in the near term. At the same time, we are seeing progress from the actions we are taking, and the challenging environment does not change our confidence in our long-term strategy.”
Kimberly-Clark reported third quarter 2026 net sales of $4.1 billion, down 0.4%, with organic sales declining 1.3% due to social media disruptions in China and inventory movements in North America. Adjusted EPS from continuing operations rose 17.2% to $1.70, while the company highlighted the completion of its Kenvue transaction as a defining strategic milestone.
Term
Q3 2026
“The completion of our Kenvue transaction earlier this week marks a defining moment in the 154 year history of Kimberly-Clark. We embark on an exciting next chapter focused on delivering better care, in more hands, and enabling smarter health.”
Mike Hsu, Kimberly-Clark Chairman and CEO
“Our third quarter results reflect a dynamic operating environment and several discrete impacts. Our team continues to execute with agility, and the underlying momentum of our business remains strong.”
Agios Pharmaceuticals reported Q3 2026 financial results, highlighted by record quarterly net product revenue of $55.4 million, a four-fold increase year-over-year driven by the U.S. launch of AQVESME in thalassemia. The company ended the quarter with $907 million in cash and is preparing for a potential February 2027 FDA approval of mitapivat in sickle cell disease.
Term
Q3 2026
“The third quarter was a record for our product revenue, outperforming our entire 2025 total in just three months. This growth was driven by the U.S. commercial launch of AQVESME in thalassemia, where broadening demand is translating into a durable base of patients on therapy.”
Brian Goff, Chief Executive Officer
“This launch has built the commercial foundation for our largest indication opportunity with mitapivat – sickle cell disease. Our conviction in mitapivat for patients with sickle cell disease is grounded in the robust efficacy and safety data generated to date and we are launch-ready ahead of our PDUFA goal date of February 1, 2027.”
United Parks & Resorts reported third quarter 2026 results with total revenue of $506.5 million and net income of $80.0 million, both down slightly year-over-year due to unfavorable weather and international headwinds. Despite a 4.7% decline in attendance, the company achieved record in-park per capita spending of $37.39 and reported an 8% increase in total pass sales.
Term
Q3 2026
“We are pleased with the underlying performance of our business, despite significantly unfavorable weather, calendar impacts and international headwinds during the quarter. Excluding the impact of these unusual headwinds, which amounted to approximately 325,000 visits, our attendance would have been up.”
Marc Swanson, CEO of United Parks & Resorts Inc.
“Looking ahead to 2027 and beyond, we see a clear path to deliver significantly higher attendance, revenue, Adjusted EBITDA and free cash flow.”
NCR Voyix reported third quarter 2026 financial results with revenue of $539 million, reflecting the impact of its hardware business transition. The company reported net income from continuing operations of $14 million and maintained its full-year 2026 outlook, though it now expects revenue to be at the lower end of its previously stated range.
“Our third quarter results were in line with our expectations, with our strong customer signings reflecting increasing demand for our Voyix Commerce Platform applications. The growth in remaining contract value, coupled with the progress we have made in scaling our deployments, reinforces our confidence in the opportunity ahead.”
James G. Kelly, Chief Executive Officer of NCR Voyix
Perimeter Group reported Q3 2026 financial results with net sales increasing 24% to $389.9 million and net income of $304.5 million. The company also completed its corporate name change from Perimeter Solutions, Inc. and integrated the $117.1 million acquisition of Monaco Enterprises.
InfuSystem Holdings reported Q3 2026 net revenues of $37.6 million, a 3% increase year-over-year, driven by strong growth in Oncology and Wound Care. Net income rose to $3.2 million, or $0.15 per diluted share, while Adjusted EBITDA margin expanded to 24.9%. The company reaffirmed its full-year 2026 guidance, expecting pro-forma revenue growth of 6% to 8%.
Term
Q3 2026
“We delivered another strong quarter, achieving record revenue of $37.6 million. After adjusting for the impact of the previously announced GE Healthcare contract restructuring, pro-forma revenue increased 10.2% compared to the prior-year period. Pro-forma growth has accelerated each quarter this year, up from 1.7% in the first quarter and 7.5% in the second quarter. We also increased Adjusted EBITDA by 12.5% and expanded Adjusted EBITDA margin to 24.9% from 22.8% in the prior-year period. These results reflect continued execution of our profitable growth strategy across our diversified operating platform.”
Carrie Lachance, Chief Executive Officer
“Growth during the quarter was driven by Oncology, where revenue grew 7.2%, and exceptional performance in Wound Care. Wound Care revenue increased $2.0 million, or 112%, compared to the prior-year period, including approximately $1.6 million of growth from our compression therapy product lines focused on lymphedema treatment.”
Evommune Licensing Deal with Hinova Pharmaceuticals Inc.
Evommune announced it has entered into an exclusive license agreement with Hinova Pharmaceuticals for EVO570, an oral VAV1-directed molecular glue degrader. Evommune acquired worldwide rights (excluding Greater China) to develop, manufacture, and commercialize the candidate, which it plans to develop for rheumatoid arthritis.
Becton, Dickinson and Company (BD) reported Q4 fiscal 2026 revenue of $5.3 billion, a 5.4% increase, and full-year revenue of $19.5 billion. The company highlighted the completion of its transformation into a more focused MedTech company following the separation of its Life Sciences business and issued guidance for fiscal 2027.
“We delivered a strong fourth quarter, with 5.6% revenue growth and broad-based performance led by our key growth platforms. Fiscal 2026 was a defining year as we completed BD's transformation to a more focused MedTech company with separation of our Life Sciences business. We strengthened our core growth and expanded BD Excellence to elevate our commercial capabilities, accelerate innovation and drive greater productivity. We enter fiscal 2027 from a position of strength, with a portfolio built for durable performance and confidence in the long-term growth, earnings and cash-flow potential of New BD.”
Advance Auto Parts reported Q3 2026 net sales of $2.01 billion, a 1.2% decrease in comparable store sales. Despite a volatile demand environment, the company delivered an adjusted operating margin of 4.5% and raised its full-year free cash flow guidance to approximately $150 million.
Term
Q3 2026
“Our comparable sales performance improved as the quarter progressed. Main Street Pro outperformed throughout the quarter while DIY trends improved compared to the softer trends experienced during the summer. I thank the team for their hard work and commitment to serving our customers.”
Shane O'Kelly, president and chief executive officer
“Sales declined in the low-single-digit range during the first eight weeks before turning positive in the final four weeks, supported by improved transaction volumes. The Pro channel led performance in Q3, with low-single-digit sales growth including stronger Main Street Pro growth.”
Shane O'Kelly, president and chief executive officer
Sunshine Silver Mining & Refining completed its 50,000-meter infill drill program at the Sunshine Mine in Idaho, reporting high-grade silver results exceeding 1,000 gpt across multiple veins. The data will support an updated Mineral Resource Estimate in Q1 2027 and a Feasibility Study in Q2 2027 as the company targets a return to production in late 2028.
LeMaitre Vascular reported net sales of $68.0 million for Q3 2026, a 11% increase over the prior year, though net income decreased to $15.0 million from $17.4 million. For the nine months ended September 30, 2026, the company saw improved profitability with net income rising to $47.8 million compared to $42.2 million in the same period of 2025.
Graham Corp reported second quarter fiscal 2027 results with net sales increasing 6% to $69.8 million and net income rising 50% to $4.6 million. The company achieved a record backlog of $561.3 million and reaffirmed its full-year fiscal 2027 guidance for sales and adjusted EBITDA.
Term
Q2 2027
“Our second quarter results reflect strong execution across the business, highlighted by growth in Defense and Space, significant margin expansion and continued momentum across our end markets. Our record backlog of $561 million provides strong visibility into future growth and reinforces our confidence in the long-term opportunities ahead.”
Matthew J. Malone, President and Chief Executive Officer
“We are very pleased with the progress of FlackTek’s integration and the continued execution of our strategic initiatives, including the successful completion of our first customer test at our new cryogenic testing facility and the groundbreaking of our new facility in Arvada.”
Matthew J. Malone, President and Chief Executive Officer
Aspen Aerogels reported Q3 2026 revenue of $85.2 million, a 71% increase quarter-over-quarter, driven by growth in both Thermal Barrier and Energy Industrial segments. The company reported a net loss of $10.4 million, which included $15.1 million in costs related to an incident at its East Providence facility, while Adjusted EBITDA reached $19.8 million. Additionally, the company appointed Stacy D. Nieuwoudt to its Board of Directors, increasing the board size to seven members.